Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Free Study: Early Switch to Trizivir in HIV-1
NCT00405925Phase 3Completed
- Sponsor
- Rijnstate
- Start
- Mar 2003
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by Rijnstate. Started Mar 2003; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00405925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405925.